T
THNR
OtherAmplify Weight Loss Drug & Treatment ETF
$23.66
-0.02%
Live · NYSE ARCA · Mar 28, 6:08 AM
AI InsightNo insight available
What's Moving THNR Today?
No AI insight has been generated for THNR yet. Check back soon — insights are generated from recent news analysis.
Generated Insights
No insights have been generated for THNR yet. Check back soon.
THNR News
6 articles- FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFsYahoo Finance·Mar 23, 2026
- Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookYahoo Finance·Feb 4, 2026
- The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo DrugYahoo Finance·Dec 29, 2025
- Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest inYahoo Finance·Nov 24, 2025
- NVO Wins FDA Approval for MASH Treatment: ETFs Likely to GainYahoo Finance·Aug 19, 2025
- Weight-Loss Drug ETFs Generate Skinnier Returns Than ExpectedThedailyupside·Jun 11, 2025
All 6 articles loaded
Price Data
Open$0.00
Previous Close$23.66
Day High$0.00
Day Low$0.00
52 Week High$27.28
52 Week Low$18.56
52-Week Range
$18.56$27.28
$23.66
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield1.75%
Dividend / Share$0.41
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)2K
Shares Outstanding170K
About Amplify Weight Loss Drug & Treatment ETF
Amplify Weight Loss Drug & Treatment ETF (THNR) · Other
Listed May 20, 2024
Company Details
Security TypeETF
ExchangeNYSE Arca
CurrencyUSD
Round Lot100
SIC—
CIK0001633061
Composite FIGIBBG01MZLGHG3
Share Class FIGIBBG01MZLGJ97